JESSICA SMITH: Open Payments
NPI 1376996629 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,126 in 83 payments from 20 companies in 2025. Trend: 2023 $310 · 2024 $475 · 2025 $2,126
Food & beverage: $1,861Education: $265
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $572 |
| GENZYME CORPORATION | 9 | $259 |
| UCB, Inc. | 11 | $223 |
| Lilly USA, LLC | 9 | $166 |
| ABBVIE INC. | 9 | $157 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $73 |
| LEO Pharma Inc. | 3 | $73 |
Products named: TREMFYA, DUPIXENT, Bimzelx, TALTZ, SKYRIZI, SILIQ, ADBRY, COSENTYX.
Industry payments across KY — which companies pay providers there.
